Brand Reference: Estrace Vaginal
| Metric | Verified Benchmark | Source |
|---|---|---|
| Estradiol Vaginal Cream 0.01% RxNorm Concept ID | 197661 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.6900 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $164.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $19.40 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $24.00 / mo | 24 Zero-PHI Verified Patient Logs |
Restores stratified squamous vaginal and periurethral epithelium glycogen stores, re-colonizes protective Lactobacillus acidophilus flora, lowers vaginal pH below 4.5, and cuts recurrent postmenopausal UTIs by >50% with near-baseline systemic serum estradiol.
Across 24 community cost disclosures for Estradiol Vaginal Cream 0.01% (Estrace Vaginal), cash buyers routing around $164.00 retail markups capture a 88% discount ($19.40/mo benchmark vs $0.6900 NADAC acquisition).
Following administration (1 g intravaginally nightly x 14 days loading), Estradiol Vaginal Cream 0.01% achieves < 5% systemic spillover after mucosal maturation bioavailability and 2–4 weeks mucosal elasticity and ph normalization onset, governed by a Local mucosal retention 48–72 hours terminal half-life through local mucosal sulfation and glucuronidation.
Before initiating Estradiol Vaginal Cream 0.01% at 1 g intravaginally nightly x 14 days loading, clinical safety checklists rule out undiagnosed genital tract bleeding; known estrogen-receptor-positive pelvic malignancy without oncology sign-off. Logged tolerability patterns center on local cream discharge (17% of reports), mild initial pelvic fullness (6% of reports).
Across 24 verified cash-pay logs, Estradiol Vaginal Cream 0.01% achieves a 94.00% Worth-It rating with out-of-pocket spend averaging $24.00/mo versus $164.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 1 g intravaginally nightly x 14 days loading for Estradiol Vaginal Cream 0.01%; monthly out-of-pocket dropped to $17.07 compared with $164.00 retail.
Completed 10 weeks on Estradiol Vaginal Cream 0.01% (1 g intravaginally twice weekly maintenance). Zero notable side effects on steady dosing.
Consistent biomarker response on 1 g intravaginally nightly x 14 days loading Estradiol Vaginal Cream 0.01% sourced via TeleMed ($22.50/mo cash pay without insurance prior authorization).